Applications of coronary intervention in the management of ischemic left ventricular dysfunction

被引:0
|
作者
Vetrovec, G [1 ]
Lipinski, M [1 ]
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia Hosp, Richmond, VA 23284 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In summary PCI has shown progressive improvement in outcome. The impact of these results, coupled with improved adjuctive medical therapy, make PCI a more competitive and attractive treatment for patients with multi-vessel disease and reduced (ideally viable) left ventricular function Aggressive strategies in this patient population are associated with improved outcomes.
引用
收藏
页码:183 / 186
页数:4
相关论文
共 50 条
  • [31] Coronary artery bypass grafting is superior to percutaneous coronary intervention in patients with left ventricular dysfunction COMMENT
    Mestres, Carlos A.
    Van Hemelrijck, Mathias
    Sromicki, Juri
    JOURNAL OF CARDIAC SURGERY, 2021, 36 (10) : 3843 - 3845
  • [32] Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients with Left Ventricular Systolic Dysfunction
    Khan, Mahin R.
    Kayani, Waleed T.
    Pelton, Jason
    Ansari, Ahmed
    Paniagua, David
    Khalid, Umair
    Denktas, Ali
    Changezi, Hameem U.
    Munir, Ahmad
    Jimenez, Ernesto
    Alam, Mahboob
    Jneid, Hani
    CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (03) : 575 - 585
  • [33] Outcomes After Percutaneous Coronary Intervention for Patients With Stable Coronary Disease and Left Ventricular Systolic Dysfunction
    DeVore, Adam D.
    Yow, Eric
    Krucoff, Mitchell W.
    Shaw, Linda K.
    Chiswell, Karen
    O'Connor, Christopher M.
    Ohman, E. Magnus
    Velazquez, Eric J.
    CIRCULATION, 2014, 130
  • [34] Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients with Left Ventricular Systolic Dysfunction
    Mahin R. Khan
    Waleed T. Kayani
    Jason Pelton
    Ahmed Ansari
    David Paniagua
    Umair Khalid
    Ali Denktas
    Hameem U. Changezi
    Ahmad Munir
    Ernesto Jimenez
    Mahboob Alam
    Hani Jneid
    Cardiovascular Drugs and Therapy, 2021, 35 : 575 - 585
  • [35] Statins decrease mortality in patients undergoing percutaneous coronary intervention with left ventricular dysfunction
    Lipinski, MJ
    Martin, RE
    Cowley, MJ
    Goudreau, E
    Malloy, WN
    Vetrovec, GW
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 160A - 160A
  • [36] Coronary collaterals provide a constant scaffold effect on the left ventricle and limit ischemic left ventricular dysfunction in humans
    Hoole, Stephen P.
    White, Paul A.
    Read, Philip A.
    Heck, Patrick M.
    West, Nick E.
    O'Sullivan, Michael
    Dutka, David P.
    JOURNAL OF APPLIED PHYSIOLOGY, 2012, 112 (08) : 1403 - 1409
  • [37] Management of asymptomatic left ventricular dysfunction
    Haas, GJ
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2001, 68 (03) : 249 - 255
  • [38] Determinants of outcome in patients with chronic ischemic left ventricular dysfunction undergone percutaneous coronary interventions
    Enrico Ammirati
    Valentina Guida
    Azeem Latib
    Francesco Moroni
    Francesco Arioli
    Isabella Scotti
    Ornella E. Rimoldi
    Antonio Colombo
    Paolo G. Camici
    BMC Cardiovascular Disorders, 15
  • [39] Determinants of outcome in patients with chronic ischemic left ventricular dysfunction undergone percutaneous coronary interventions
    Ammirati, Enrico
    Guida, Valentina
    Latib, Azeem
    Moroni, Francesco
    Arioli, Francesco
    Scotti, Isabella
    Rimoldi, Ornella E.
    Colombo, Antonio
    Camici, Paolo G.
    BMC CARDIOVASCULAR DISORDERS, 2015, 15
  • [40] Clinical outcome following coronary artery stenting in patients with severe ischemic left ventricular dysfunction
    Zhang, SY
    Ventura, H
    Ramee, EJ
    Jain, SP
    Jenkins, JS
    Collins, T
    White, CJ
    Ramee, SR
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 : TC131 - TC131